Dr. Beth Ami Leeman-Markowski, MD

Dr. Leeman-Markowski practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Leeman-Markowski's NPI, 1245206788, was assigned on February 24, 2006. Dr. Leeman-Markowski graduated from Washington University School of Medicine in 2001. Dr. Leeman-Markowski holds Massachusetts license 224957.

Dr. Leeman-Markowski's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Leeman-Markowski's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Leeman-Markowski is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Leeman-Markowski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leeman-Markowski practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Leeman-Markowski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Leeman-Markowski is licensed in Massachusetts.

CMS data shows 57 Medicare services from Dr. Leeman-Markowski across 2 procedure codes in 2024, all of them office visits, for 32 Medicare patients. Medicare paid $6,492 for them. Every service was in an office.

CMS counts 32 Medicare patients who saw Dr. Leeman-Markowski in 2024. The largest group is under 65, with 13 patients. 69% of them have high cholesterol, and 56% have high blood pressure. 41% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Leeman-Markowski's median patient age at 40, with 52% women.

In 2024, Dr. Leeman-Markowski wrote 689 Medicare Part D claims for 42 patients. 87% of them were for generic drugs. CMS names the drug for 563 of them, across 19 drugs with 11 or more claims each, at $584,655 in total drug cost. In 2023, CMS named 600 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Leeman-Markowski for performance year 2024, reported as part of a group. Dr. Leeman-Markowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leeman-Markowski as offering telehealth.

Dmand AI links 11 papers to Dr. Leeman-Markowski, published from 2014 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Epilepsy, Seizures and Electroencephalography. Dr. Leeman-Markowski has published most often in Epilepsy Behav. Dr. Leeman-Markowski's most frequent co-authors are Kimford Jay Meador, MD, Orrin Devinsky, MD and Patricia Cristine Dugan, MD.

Dmand AI links Dr. Leeman-Markowski to 2 clinical trials, 2 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Epilepsy, Seizures and Brain Diseases.

Dr. Leeman-Markowski graduated from Washington University School of Medicine in 2001.